🔎 Trials Near Me

Home › Movement Disorders › Massachusetts › Boston

Movement Disorders clinical trials in Boston, MA

6 studies for Movement Disorders are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease

RecruitingPhase 1/2
  • Beth Israel Deaconess Medical Center, Boston
Ages 25 to 65 · All sexes · Updated May 5, 2026 · NCT06826612

Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)

RecruitingObservational study
  • Boston Children's Hospital, Boston
1 Month – 30 Years · All sexes · Updated Mar 18, 2026 · NCT05354622

A Multicenter Pediatric Deep Brain Stimulation Registry

RecruitingObservational study
  • Boston Children's Hospital, Boston
Ages 0 to 18 · All sexes · Updated Mar 18, 2026 · NCT06585618

A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes

RecruitingObservational study
  • Boston Children's Hospital, Boston
Ages 0 to 18 · All sexes · Updated Mar 18, 2026 · NCT06585605

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

RecruitingObservational studyHealthy volunteers welcome
  • Massachusetts General Hospital, Boston
Ages 18 and older · All sexes · Updated Nov 21, 2025 · NCT05137665

Registry and Natural History of Epilepsy-Dyskinesia Syndromes

RecruitingObservational study
  • Boston Children's Hospital, Boston
Ages 0 to 30 · All sexes · Updated Aug 17, 2025 · NCT06967727

About Movement Disorders

Movement disorders can be caused by nerve diseases, autoimmune diseases, infections and more. Many movement disorders are inherited.

More about Movement Disorders on MedlinePlus

Movement Disorders trials in other cities

Other studies in Boston

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.